Significant Ownership of Julian C. Baker
- Location
- New York, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Julian C. Baker.
Follow Filing Activity
Follow Julian C. Baker and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Julian C. Baker
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc. | Common Stock, $0.0001 par value per share | 25% | $1,162,886,859 | 43,294,373 | Julian C. Baker | 24 Feb 2026 | ||
| ONC | BeOne Medicines Ltd. (f/k/a BeiGene Ltd.) | Ordinary Shares, par value $0.0001 per share | 8% | $34,424,296,187 | 115,918,313 | Julian C. Baker | 16 Apr 2026 |
Schedules 13D/G Reported by Julian C. Baker:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.